Management of Breakthrough Bleeding with Combined Hormonal Contraceptives

Initial Counseling and Reassurance

Breakthrough bleeding and spotting are common side effects during the first 3-6 months of combined hormonal contraceptive use and generally improve with continued use 1
These bleeding irregularities are not harmful and do not indicate reduced contraceptive effectiveness 1, 2
Emphasize the importance of consistent pill-taking, as missed or irregular dosing increases breakthrough bleeding 1
Consistent daily timing of pill-taking reduces breakthrough bleeding episodes 1

NSAIDs are the recommended first-line treatment for breakthrough bleeding on combined hormonal contraceptives 2, 3
Specific options include mefenamic acid (500 mg three times daily) or ibuprofen 3
Treatment should be given during days of active bleeding only 2, 3

Consider evaluation for interactions with other medications (particularly enzyme-inducing drugs) 3
Consider evaluation for sexually transmitted infections 4
Consider evaluation for pregnancy 1
Consider evaluation for new pathologic uterine conditions (polyps, fibroids) 3

For extended or continuous regimens, a 3-4 day hormone-free interval can be considered 2, 4
This approach is not recommended during the first 21 days of extended/continuous use 2, 4
This approach is not recommended more than once per month as contraceptive effectiveness may be reduced 2, 4

Advise patients to return at any time to discuss side effects or concerns 2
No routine follow-up visit is required unless bleeding persists beyond 3-6 months or worsens 2
If bleeding pattern changes abruptly or becomes heavy/prolonged, reevaluate for underlying pathology 2, 3